LVM Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

LVM Capital Management’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-23,000	Closed	-$252K	–	147
2023 Q2	$252K	Hold	23,000	–	–	0.03%	126
2023 Q1	$201K	Buy	23,000 +13,000	+130%	+$104K	0.03%	135
2022 Q4	$63K	Hold	10,000	–	–	0.01%	132
2022 Q3	$35K	Hold	10,000	–	–	0.01%	130
2022 Q2	$30K	Buy	+10,000	New	+$23.9K	﹤0.01%	129
2021 Q4	–	Sell	-15,000	Closed	-$55K	–	134
2021 Q3	$55K	Hold	15,000	–	–	0.01%	125
2021 Q2	$65K	Hold	15,000	–	–	0.01%	126
2021 Q1	$68K	Sell	15,000 -1,000	-6%	-$5.38K	0.01%	124
2020 Q4	$92K	Hold	16,000	–	–	0.02%	120
2020 Q3	$116K	Hold	16,000	–	–	0.02%	104
2020 Q2	$56K	Hold	16,000	–	–	0.01%	103
2020 Q1	$24K	Hold	16,000	–	–	0.01%	100
2019 Q4	$31K	Hold	16,000	–	–	0.01%	116
2019 Q3	$82K	Hold	16,000	–	–	0.02%	113
2019 Q2	$115K	Hold	16,000	–	–	0.03%	107
2019 Q1	$212K	Sell	16,000 -10,000	-38%	-$106K	0.05%	106
2018 Q4	$205K	Hold	26,000	–	–	0.05%	101
2018 Q3	$288K	Hold	26,000	–	–	0.07%	99
2018 Q2	$349K	Buy	26,000 +5,000	+24%	+$62.6K	0.08%	84
2018 Q1	$273K	Hold	21,000	–	–	0.06%	100
2017 Q4	$193K	Hold	21,000	–	–	0.04%	112
2017 Q3	$169K	Buy	21,000 +1,000	+5%	+$6.76K	0.04%	113
2017 Q2	$115K	Buy	20,000 +10,000	+100%	+$42.6K	0.03%	114
2017 Q1	$43K	Buy	+10,000	New	+$28.7K	0.01%	114

Other funds holding CBAY

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

LVM Capital Management's CBAY Position: Q3 2023 in Review

LVM Capital Management sold out of Cymabay Therapeutics (CBAY) in Q3 2023, closing a stake of 23,000 shares — an estimated $252K sold.

LVM Capital Management first reported a position in CBAY in Q1 2017 and held it in 24 quarters. The position peaked at $349K in Q2 2018. 189 funds tracked by Wall St. Rank hold CBAY as of Q3 2023.

LVM Capital Management reported no remaining Cymabay Therapeutics position as of Q3 2023 after selling out during the quarter.
LVM Capital Management sold 23,000 Cymabay Therapeutics shares in Q3 2023, an estimated $252K.
LVM Capital Management first reported a position in Cymabay Therapeutics in Q1 2017 and held it in 24 quarters.
LVM Capital Management's Cymabay Therapeutics position peaked at $349K in Q2 2018.
189 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q3 2023.

Based on LVM Capital Management's 13F filing for Q3 2023, filed 10 Oct 2023.